Average Insider

Where insiders trade, we follow

Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER
CIK: 1882909

All Transactions

DateCompanyTypeSharesPriceValueActions
Feb 3, 2026Travere Therapeutics, Inc. (TVTX)S4,333$32.12$139,175.96View Details Filing
Jan 31, 2026Travere Therapeutics, Inc. (TVTX)A20,160$0.00$0.00View Details Filing
Jan 31, 2026Travere Therapeutics, Inc. (TVTX)A15,180$0.00$0.00View Details Filing
Dec 24, 2025Travere Therapeutics, Inc. (TVTX)S7,402$40.00$296,080.00View Details Filing
Version: v26.3.23